专家洞见

GLG的专家团拥有约 100 万名成员，涵盖所有主要行业与地区的意见领袖。
在此可浏览部分专家的观点。

按洞见类型 全部
全部文章案例研究视频白皮书播客
Biogen’s Aduhelm: An Update on the Commercial Rollout
文章

Biogen’s Aduhelm: An Update on the Commercial Rollout

Alzheimer’s, Biogen, Pharmaceutical Industry, Healthcare and Life Sciences
FDA’s Controversial Aduhelm Approval: What Happens Next?
文章

FDA’s Controversial Aduhelm Approval: What Happens Next?

Alzheimer’s, Biogen, Pharmaceutical Industry, Healthcare and Life Sciences
Why the FDA Was Correct in Approving Biogen’s Aducanumab
文章

Why the FDA Was Correct in Approving Biogen’s Aducanumab

Alzheimer’s, Health Care, Healthcare and Life Sciences

订阅 GLG 洞见趋势月度专栏

输入您的电子邮件，接收我们的月度通讯，获取来自全球约 100 万名 GLG 专家团成员的专业洞见。